Updated:
Pharmscript
Pharmscript is a single-family office in Somerset, New Jersey, managing pharmaceutical-derived wealth through direct real estate and private credit...
Pharmscript
Pharmscript was established as a family office in Somerset, New Jersey, with wealth originating from the pharmaceutical sector. The firm does not publicly disclose its founding year or the identity of its founding principals. The family office invests across multiple asset classes including real estate, private credit, and healthcare-related assets. Its portfolio includes direct property investments in the New Jersey region and private credit deals structured as direct loans to mid-market companies. Geographic focus remains primarily within the United States, with a concentration in the mid-Atlantic and Northeast corridors. Pharmscript maintains a lean operational structure typical of single-family offices that prioritize privacy. No team size or additional office locations are publicly available. The firm does not operate a public website, LinkedIn profile, or marketing materials, and no recent operational events have been documented in the public domain. The firm's structural differentiator is its deliberate opacity and narrow geographic footprint. Unlike multi-family offices that market to external capital, Pharmscript appears to operate exclusively for a single family, with no fund vehicles or co-investment platforms disclosed. This architecture suggests a mandate focused on capital preservation and direct control rather than growth or third-party fundraising.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Somerset
Corporate office
Somerset, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Pharmscript?
The firm does not publicly disclose its investment committee or named principals. As a single-family office, decisions are likely made by family members or a small internal team, but no names are available in public records.
How does Pharmscript source proprietary deal flow?
With no public marketing presence or website, Pharmscript likely relies on personal networks and direct relationships within the pharmaceutical and real estate industries. No proprietary sourcing model has been publicly described.
Is Pharmscript structured as a single family office or does it operate more like a venture firm?
Pharmscript appears to be structured as a traditional single-family office. There is no evidence of external fundraising or venture-style vehicles, which distinguishes it from institutional asset managers or multi-family offices.
Does Pharmscript participate in fund commitments or only direct deals?
The firm's known activity centers on direct real estate investments and private credit deals. Public records do not indicate commitments to external funds or partnership vehicles, though such activity cannot be ruled out given the firm's privacy posture.
What investment stages does Pharmscript typically target?
The firm appears to focus on direct ownership in real estate and later-stage private credit, rather than early-stage venture or growth equity. No stage preferences have been formally disclosed.
Which sectors does Pharmscript explicitly avoid?
The firm does not publicly communicate exclusionary screens. Given its pharmaceutical wealth origin and healthcare-adjacent real estate holdings, it may avoid sectors outside its geographic and industry comfort zone, but this is speculative.
Where does the underlying wealth come from?
Pharmscript's wealth originates from the pharmaceutical industry, based on the firm's name and location in a region with significant pharmaceutical presence. No specific company or family branch has been publicly linked.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: